Algeria vs Serbia: Number of confirmed cases of tetanus
Algeria
0 Cases
in 2024
Serbia
0 Cases
in 2024
Algeria rank
108th
Serbia rank
108th
Number of confirmed cases of tetanus over time
- Algeria
- Serbia
How they compare
Algeria currently reports 0 Cases against 0 Cases in Serbia, a difference of 0 Cases.
The two have swapped places 20 times across 43 shared years of data; in 1974 it was Serbia ahead.
Algeria ranks 108th and Serbia ranks 108th of 210 countries.
Across the 6 decades both report, Algeria averaged higher in 3 and Serbia in 2.
Head to head by decade
| Decade | Algeria | Serbia | Difference | Ahead |
|---|---|---|---|---|
| 1970s | 79.33 Cases | 173 Cases | 93.67 Cases | Serbia |
| 1980s | 150.3 Cases | 86.5 Cases | 63.8 Cases | Algeria |
| 1990s | 35.38 Cases | 31.5 Cases | 3.88 Cases | Algeria |
| 2000s | 11.86 Cases | 10.29 Cases | 1.57 Cases | Algeria |
| 2010s | 0.1111 Cases | 2.56 Cases | 2.44 Cases | Serbia |
| 2020s | 0.6667 Cases | 0.6667 Cases | 0 Cases | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of confirmed cases of tetanus, Algeria or Serbia?
- Algeria, at 0 Cases against 0 Cases in Serbia as of 2024.
- What is the difference in number of confirmed cases of tetanus between Algeria and Serbia?
- 0 Cases, with Algeria ahead.
- How many years of comparable data are there for Algeria and Serbia?
- 43 years are reported by both, from 1974 to 2024.
- How do Algeria and Serbia rank globally for number of confirmed cases of tetanus?
- Algeria ranks 108th and Serbia ranks 108th of 210 countries.
- Where does this data come from?
- World Health Organization – Global Health Observatory (2026) – with minor processing by Our World in Data, published as Number of confirmed cases of tetanus. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The annual number of confirmed cases of tetanus. Confirmed numbers underestimate the actual number of tetanus cases, due to limited testing and reporting capacity.